Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-05

FDA Approved: DEFLAZACORT — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved the original Abbreviated New Drug Application for Deflazacort from Upsher-Smith Laboratories, granting a generic version of deflazacort for Duchenn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEFLAZACORT (Deflazacort)

Snippet

ORIG AP for DEFLAZACORT (DEFLAZACORT)